Rating Change
Oppenheimer reiterated its Outperform rating on MediWound Ltd. (NASDAQ:MDWD) on August 14, 2026.
reiterateNASDAQ:MDWD
Oppenheimer Reiterates Outperform Rating on MediWound Ltd. (MDWD)
Oppenheimer reiterated its Outperform rating on MediWound Ltd. (NASDAQ:MDWD) on August 14, 2026.
At publication ·
What changed
MediWound Ltd. (NASDAQ:MDWD) · reiterate
- Firm
- Oppenheimer
- Rating
- Outperform to Outperform
- Price at event
- $13.56
- Market capitalization
- $209.5M
At a glance
Key takeaways
- Oppenheimer reiterated an Outperform rating on MediWound Ltd. (MDWD) on August 14, 2026, with the stock trading at $13.56 and a market capitalization of $209.5 million.
Market Context
MediWound Ltd. operates in the Healthcare sector. The stock currently trades at $13.56 with a market capitalization of $209.5M. The stock has declined 27.7% over the past 52 weeks.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MediWound Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for MediWound Ltd.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Oppenheimer | Outperform | N/A |
| May 28, 2026 | Oppenheimer | Outperform | N/A |
| May 28, 2026 | HC Wainwright & Co. | Buy | N/A |
| Nov 21, 2025 | HC Wainwright & Co. | Buy | N/A |
| May 22, 2025 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View MDWD Stock Page
Frequently Asked Questions
What does the Outperform rating mean for MDWD?
A rating of Outperform from Oppenheimer reflects the analyst's outlook on MediWound Ltd. (NASDAQ:MDWD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MDWD forecast page.
